JBIO Competitors & Alternatives
Compare Jade Biosciences, Inc. with similar stocks in the same industry
Biotechnology
JBIO
Main Stock$21.90
Tradestie Score
52
Market Cap
$297.23M
Analyst Upside
+121.5%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$18.62
|
$1.50B | 8.8 | 66 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$48.16
|
$1.50B | - | 52 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$17.00
|
$1.49B | - | 63 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$28.80
|
$1.43B | - | 55 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.64
|
$1.42B | - | 64 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.98
|
$1.35B | - | 58 | Compare |
|
MPLT
MPLT
|
$30.65
|
$1.35B | - | 53 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$40.00
|
$1.32B | - | 64 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.40
|
$1.29B | 102.9 | 67 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$30.39
|
$1.29B | - | 63 | Compare |
More JBIO Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry